U.S. Clinical Trial: Uvax Bio Listed a New Clinical Trial to Study Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    Contify Life Science News. 2024.